enkephalin, d-penicillamine (2,5)- has been researched along with 6'-guanidinonaltrindole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fong, J; Jones, RM; Kostenis, E; Lunzer, MM; Portoghese, PS; Sharma, SK; Waldhoer, M; Whistler, JL | 1 |
| Ansonoff, MA; Pintar, JE; Portoghese, PS | 1 |
2 other study(ies) available for enkephalin, d-penicillamine (2,5)- and 6'-guanidinonaltrindole
| Article | Year |
|---|---|
A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers.
Topics: Analgesics; Cell Line; Dimerization; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Guanidines; Humans; Kidney; Kinetics; Naltrexone; Receptors, G-Protein-Coupled; Receptors, Opioid; Transfection | 2005 |
Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands.
Topics: Amides; Animals; Dose-Response Relationship, Drug; Enkephalin, D-Penicillamine (2,5)-; Guanidines; Ligands; Male; Mice; Mice, Knockout; Naltrexone; Oligopeptides; Pain; Protein Multimerization; Receptors, Opioid, delta; Receptors, Opioid, kappa | 2010 |